|
๐
|
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
57 auth.
C. Furberg,
J. Wright,
B. Davis,
J. Cutler,
M. Alderman,
H. Black,
W. Cushman,
R. Grimm,
L. Haywood,
F. Leenen,
S. Oparil,
J. Probstfield,
P. Whelton,
C. Nwachuku,
D. Gordon,
...
M. Proschan,
Paula Einhom,
C. Ford,
L. Piller,
I. K. Dunn,
D. Goff,
S. Pressel,
Judy Bettencourt,
Barbara DeLeon,
Lara M. Simpson,
J. Blanton,
T. Geraci,
Sandra M. Walsh,
C. Nelson,
Mahboob Rahman,
Anne Juratovac,
R. Pospรญลกil,
L. Carroll,
Sheila Sullivan,
J. Russo,
G. Barone,
Rudy Christian,
S. Feldman,
T. Lucente,
D. Calhoun,
Kimo Jenkins,
Peggy McDowell,
Janice Johnson,
C. Kingry,
J. Alzate,
K. Margolis,
Leslie Ann Holland-Klemme,
B. Jaeger,
J. Williamson,
G. Louis,
Pamela Ragusa,
A. Williard,
R. L. Ferguson,
J. Tanner,
J. Eckfeldt,
R. Crow,
J. Pelosi
|
12 |
2002 |
12
๐
|
|
๐
|
Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).
18 auth.
W. Cushman,
C. Ford,
J. Cutler,
K. Margolis,
B. Davis,
R. Grimm,
H. Black,
B. Hamilton,
J. Holland,
C. Nwachuku,
...
V. Papademetriou,
J. Probstfield,
J. Wright,
M. Alderman,
R. Weiss,
L. Piller,
Judy Bettencourt,
Sandra M. Walsh
|
9 |
2002 |
9
๐
|
|
๐
|
Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial.
43 auth.
E. Perin,
James T. Willerson,
C. J. Pepine,
Timothy D. Henry,
Stephen G. Ellis,
David X. M. Zhao,
Guilherme V Silva,
D. Lai,
James D. Thomas,
Marvin W Kronenberg,
A. D. Martin,
R. D. Anderson,
J. Traverse,
Marc S. Penn,
S. Anwaruddin,
...
A. Hatzopoulos,
Adrian P. Gee,
Doris A. Taylor,
C. Cogle,
Deirdre Smith,
Lynette Westbrook,
James Chen,
E. Handberg,
Rachel E. Olson,
Carrie Geither,
Sherry Bowman,
Judy Francescon,
S. Baraniuk,
L. Piller,
Lara M. Simpson,
Catalin Loghin,
D. Aguilar,
Sara Richman,
C. Zierold,
Judy Bettencourt,
Shelly L. Sayre,
Rachel W. Vojvodic,
S. Skarlatos,
David J. Gordon,
R. F. Ebert,
Minjung Kwak,
L. Moye,
R. Simari
|
8 |
2012 |
8
๐
|
|
๐
|
Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators.
12 auth.
J. Plehn,
B. Davis,
F. Sacks,
J. Rouleau,
M. Pfeffer,
V. Bernstein,
...
T. Cuddy,
L. Moye,
L. Piller,
J. Rutherford,
Lara M. Simpson,
E. Braunwald
|
8 |
1999 |
8
๐
|
|
๐
|
Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.
45 auth.
J. Traverse,
T. Henry,
S. Ellis,
C. Pepine,
J. Willerson,
David X M Zhao,
J. Forder,
B. Byrne,
A. Hatzopoulos,
M. Penn,
E. Perin,
K. Baran,
J. Chambers,
C. Lambert,
Ganesh Raveendran,
...
D. Simon,
D. Vaughan,
Lara M. Simpson,
A. Gee,
Doris A Taylor,
C. Cogle,
James D. Thomas,
G. Silva,
Beth C. Jorgenson,
Rachel E. Olson,
Sherry Bowman,
Judy Francescon,
Carrie Geither,
E. Handberg,
Deirdre Smith,
S. Baraniuk,
L. Piller,
Catalin Loghin,
D. Aguilar,
Sara Richman,
C. Zierold,
Judy Bettencourt,
Shelly L. Sayre,
Rachel W. Vojvodic,
S. Skarlatos,
D. Gordon,
R. F. Ebert,
Minjung Kwak,
L. Moye,
R. Simari
|
8 |
2011 |
8
๐
|
|
๐
|
Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.
47 auth.
J. Traverse,
T. Henry,
C. Pepine,
J. Willerson,
David X M Zhao,
S. Ellis,
J. Forder,
R. Anderson,
A. Hatzopoulos,
M. Penn,
E. Perin,
J. Chambers,
K. Baran,
Ganesh Raveendran,
C. Lambert,
...
A. Lerman,
D. Simon,
D. Vaughan,
D. Lai,
A. Gee,
Doris A Taylor,
C. Cogle,
James D. Thomas,
Rachel E. Olson,
Sherry Bowman,
Judy Francescon,
Carrie Geither,
E. Handberg,
Casey Kappenman,
Lynette Westbrook,
L. Piller,
Lara M. Simpson,
S. Baraniuk,
Catalin Loghin,
D. Aguilar,
Sara Richman,
C. Zierold,
D. Spoon,
Judy Bettencourt,
Shelly L. Sayre,
Rachel W. Vojvodic,
S. Skarlatos,
D. Gordon,
R. F. Ebert,
Minjung Kwak,
L. Moye,
R. Simari
|
8 |
2012 |
8
๐
|
|
๐
|
Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemiaโTCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial
48 auth.
R. Ware,
B. Davis,
W. Schultz,
Clark Brown,
B. Aygun,
S. Sarnaik,
I. Odame,
Beng R. Fuh,
A. George,
William C Owen,
L. Luchtman-Jones,
Z. Rogers,
L. Hilliard,
Cynthia A. Gauger,
C. Piccone,
...
Margaret T. Lee,
J. Kwiatkowski,
S. Jackson,
T. Scott,
Miller,
C. Roberts,
M. Heeney,
T. Kalfa,
S. Nelson,
H. Imran,
K. Nottage,
Ofelia,
Alvarez,
M. Rhodes,
A. Thompson,
A. Jennifer,
Rothman,
K. Helton,
D. Roberts,
Jamie L. Coleman,
M. Bonner,
A. Kutlar,
N. Patel,
J. Wood,
L. Piller,
Peng Wei,
Judy P Luden,
N. Mortier,
Susan E Stuber,
N. Luban,
A. Cohen,
S. Pressel,
R. Adams
|
8 |
2016 |
8
๐
|
|
๐
|
Role of Diuretics in the Prevention of Heart Failure: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
15 auth.
B. Davis,
L. Piller,
J. Cutler,
C. Furberg,
Kay Dunn,
S. Franklin,
D. Goff,
F. Leenen,
S. Mohiuddin,
V. Papademetriou,
...
M. Proschan,
A. Ellsworth,
J. Golden,
Pedro J. Colon,
R. Crow
|
6 |
2006 |
6
๐
|
|
๐
|
Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).
18 auth.
William C. Cushman,
C. Ford,
Jeffrey A. Cutler,
Karen L. Margolis,
Barry R Davis,
Richard H. Grimm,
Henry R. Black,
Bruce P. Hamilton,
J. Holland,
C. Nwachuku,
...
V. Papademetriou,
J. Probstfield,
Jackson T. Wright,
Michael H. Alderman,
Robert J. Weiss,
L. Piller,
Judy Bettencourt,
Sandra M. Walsh
|
6 |
2002 |
6
๐
|
|
๐
|
Effect of Statin Treatment vs Usual Care on Primary Cardiovascular Prevention Among Older Adults: The ALLHAT-LLT Randomized Clinical Trial
8 auth.
Benjamin H. Han,
D. Sutin,
J. Williamson,
B. Davis,
L. Piller,
Hannah Pervin,
...
S. Pressel,
C. Blaum
|
6 |
2017 |
6
๐
|
|
๐
|
TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, randomised controlled trial
45 auth.
R. Ware,
B. Davis,
W. Schultz,
R. Brown,
B. Aygun,
S. Sarnaik,
I. Odame,
Beng R. Fuh,
A. George,
William C Owen,
L. Luchtman-Jones,
Z. Rogers,
L. Hilliard,
Cynthia A. Gauger,
C. Piccone,
...
Margaret T. Lee,
J. Kwiatkowski,
S. Jackson,
Scott T. Miller,
C. Roberts,
M. Heeney,
T. Kalfa,
S. Nelson,
H. Imran,
K. Nottage,
Ofelia A Alvarez,
M. Rhodes,
A. Thompson,
J. Rothman,
K. Helton,
D. Roberts,
Jamie L. Coleman,
M. Bonner,
A. Kutlar,
N. Patel,
J. Wood,
L. Piller,
Peng Wei,
Judy P Luden,
N. Mortier,
Susan E Stuber,
N. Luban,
A. Cohen,
S. Pressel,
R. Adams
|
6 |
2015 |
6
๐
|
|
๐
|
Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction.
25 auth.
J. Traverse,
T. Henry,
D. Vaughan,
S. Ellis,
C. Pepine,
J. Willerson,
David X M Zhao,
L. Piller,
M. Penn,
B. Byrne,
E. Perin,
A. Gee,
A. Hatzopoulos,
D. McKenna,
J. Forder,
...
Doris A Taylor,
C. Cogle,
Rachel E. Olson,
Beth C. Jorgenson,
Shelly L. Sayre,
Rachel W. Vojvodic,
D. Gordon,
S. Skarlatos,
L. Moye,
R. Simari
|
6 |
2009 |
6
๐
|
|
๐
|
Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFR.
19 auth.
Mahboob Rahman,
C. Ford,
J. Cutler,
B. Davis,
L. Piller,
P. Whelton,
J. Wright,
J. Barzilay,
C. Brown,
Pedro J. Colon,
...
Lawrence J. Fine,
R. Grimm,
Alok K. Gupta,
Charles L. Baimbridge,
L. Haywood,
Mario A. Henriquez,
Ekambaram Ilamaythi,
S. Oparil,
R. Preston
|
6 |
2012 |
6
๐
|
